Solesence Appoints Yoolie Park as VP of Brand Partnerships
Solesence has appointed Yoolie Park as Vice President of Brand Partnerships. In this role, Park will lead strategic relationships with emerging and established beauty brands, expanding Solesence's ability to deliver fully integrated, turnkey solutions that accelerate speed to market while enabling brands to deploy more working capital toward marketing and growth initiatives. Park joins Solesence from Paklab, where she held the position of Executive Vice President and was responsible for identifying new business opportunities, overseeing and maintaining brand relationships, and leading packaging and product development initiatives.
Trade with 70% Backtested Accuracy
Analyst Views on SLSN
About SLSN
About the author
Nanophase Technologies GAAP EPS of $0.04, revenue of $20.4M
Financial Performance: Nanophase Technologies reported a Q2 GAAP EPS of $0.04 and revenue of $20.4 million.
Market Developments: Solesence, Inc. is experiencing growth but faces stock price challenges, while other materials stocks are joining the Russell Microcap Index.
Solésence Expands Debt Facilities to Fuel Growth Initiatives
Loan Agreement Amendments: Solésence, Inc. has amended its loan agreements to increase borrowing capacity from $14.2 million to $23.0 million and extended the maturity date to April 30, 2027, providing financial flexibility for strategic objectives.
Company Overview: Solésence is a leader in health care solutions within beauty and life sciences, focusing on innovative mineral-based sun protection and empowering brand partners through enhanced product offerings.
Nanophase Technologies GAAP EPS of $0.04, revenue of $20.4M
Financial Performance: Nanophase Technologies reported a Q2 GAAP EPS of $0.04 and revenue of $20.4 million.
Market Developments: Solesence, Inc. is experiencing growth but faces stock price challenges, while other materials stocks are joining the Russell Microcap Index.
Solésence Expands Debt Facilities to Fuel Growth Initiatives
Loan Agreement Amendments: Solésence, Inc. has amended its loan agreements to increase borrowing capacity from $14.2 million to $23.0 million and extended the maturity date to April 30, 2027, providing financial flexibility for strategic objectives.
Company Overview: Solésence is a leader in health care solutions within beauty and life sciences, focusing on innovative mineral-based sun protection and empowering brand partners through enhanced product offerings.
